Author Correction: Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
The original version of this Article omitted the following from the end of the Acknowledgements: ‘X.C. also received funding from the Shenzhen Basic Research Program JCYJ20170818140904167.’ This has now been corrected in both the PDF and HTML versions of the Article.
Main Authors: | Li Zhong, Ying Xu, Rengong Zhuo, Tingting Wang, Kai Wang, Ruizhi Huang, Daxin Wang, Yue Gao, Yifei Zhu, Xuan Sheng, Kai Chen, Na Wang, Lin Zhu, Dan Can, Yuka Marten, Mitsuru Shinohara, Chia-Chen Liu, Dan Du, Hao Sun, Lei Wen, Huaxi Xu, Guojun Bu, Xiao-Fen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2019-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10950-2 |
Similar Items
-
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
by: Li Zhong, et al.
Published: (2019-03-01) -
Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
by: Li Zhong, et al.
Published: (2018-03-01) -
Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
by: Wenhui Qiao, et al.
Published: (2023-01-01) -
Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
by: Wenhui Qiao, et al.
Published: (2023-04-01) -
TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
by: Honghua Zheng, et al.
Published: (2018-11-01)